Cleanroom Whitepapers and Case Studies
-
Overcoming HCP Co-Elution Issues Using Cell Line Engineering
5/15/2024
Product quality assessments revealed that a customer’s therapeutic protein had a range of hydrophobic HCPs. Review a solution that took an alternative approach by utilizing cell line engineering.
-
Innovation In Filtration
3/18/2025
Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Explore how its simplicity and reliability make it indispensable.
-
Meeting Local Regulations With Ready-To-Use Buffer Solutions
1/22/2024
Learn about a ready-to-use, custom buffer solution provided to a biopharmaceutical manufacturing facility in order to help them reduce costs and the amount of time spent on QC testing and validation.
-
Reducing ADC Timelines With Integrated Development And Manufacturing
4/8/2024
ADCs have proven to be highly effective in cancer treatment, but their manufacturing poses challenges. Learn how a CDMO partner can help bring these treatments to patients safely and efficiently.
-
Prefabricated Viral Vector Modular BSL-2LS cGMP Facility In 13 Months
6/26/2024
Learn about the modular BSL-2LS cGMP facility that was constructed to support 3 processing lines for German-based CDMO Vibalogics as the company sought to expand in the U.S. market for viral vectors.
-
Improving Efficiency In Contamination Identification
7/11/2025
Discover how rapid microbial identification using MALDI-TOF improves contamination response, shortens investigation timelines, and enhances efficiency in biopharmaceutical manufacturing.
-
Comprehensive Compressed Air Assessments: The 5-Step Process
10/10/2024
The objective of this paper is to define the five steps required in a compressed air assessment. We will use a real-world example with system information from a magnetic materials manufacturer to clearly illustrate each step.
-
ABSL-3 Facility For Duke (National University of Singapore)
6/6/2024
Read about a 5-module ABSL-3 facility that was constructed in Singapore, and is used for disease surveillance, research on avian influenza, and other risk group 3 materials.
-
Enhancing Viral Clearance Prediction And Process Optimization
7/11/2025
MockV technology enables early, in-house viral clearance assessment, helping biopharma developers improve process robustness, reduce costs, and enhance safety before GMP manufacturing begins.
-
The State Of Plastics Recycling In BioPharma
8/9/2023
Recycling plastics from biomanufacturing proves uniquely difficult due to circularity, quality, and infrastructure challenges. Nonetheless, change is underway. Learn how this change is being spearheaded by industry leaders.